These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 10562690)

  • 1. Double blind randomized trial of sucralfate vs placebo during radical radiotherapy for head and neck cancers.
    Carter DL; Hebert ME; Smink K; Leopold KA; Clough RL; Brizel DM
    Head Neck; 1999 Dec; 21(8):760-6. PubMed ID: 10562690
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does sucralfate reduce the acute side-effects in head and neck cancer treated with radiotherapy? A double-blind randomized trial.
    Lievens Y; Haustermans K; Van den Weyngaert D; Van den Bogaert W; Scalliet P; Hutsebaut L; Fowler J; Lambin P
    Radiother Oncol; 1998 May; 47(2):149-53. PubMed ID: 9683362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of granulocyte-macrophage colony-stimulating factor and sucralfate mouthwashes in the prevention of radiation-induced mucositis: a double-blind prospective randomized phase III study.
    Saarilahti K; Kajanti M; Joensuu T; Kouri M; Joensuu H
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):479-85. PubMed ID: 12243825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sucralfate in the prevention of radiation-induced oral mucositis.
    Cengiz M; Ozyar E; Oztürk D; Akyol F; Atahan IL; Hayran M
    J Clin Gastroenterol; 1999 Jan; 28(1):40-3. PubMed ID: 9916664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sucralfate for radiation mucositis: results of a double-blind randomized trial.
    Meredith R; Salter M; Kim R; Spencer S; Weppelmann B; Rodu B; Smith J; Lee J
    Int J Radiat Oncol Biol Phys; 1997 Jan; 37(2):275-9. PubMed ID: 9069297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes.
    Dodd MJ; Miaskowski C; Greenspan D; MacPhail L; Shih AS; Shiba G; Facione N; Paul SM
    Cancer Invest; 2003; 21(1):21-33. PubMed ID: 12643006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sucralfate mouth washing in the prevention of radiation-induced mucositis: a placebo-controlled double-blind randomized study.
    Makkonen TA; Boström P; Vilja P; Joensuu H
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):177-82. PubMed ID: 8083112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathological evaluation of sucralfate in prevention of oral mucositis induced by radiation therapy in patients with head and neck malignancies.
    Etiz D; Erkal HS; Serin M; Küçük B; Hepari A; Elhan AH; Tulunay O; Cakmak A
    Oral Oncol; 2000 Jan; 36(1):116-20. PubMed ID: 10889930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral mucositis prevention by low-level laser therapy in head-and-neck cancer patients undergoing concurrent chemoradiotherapy: a phase III randomized study.
    Gouvêa de Lima A; Villar RC; de Castro G; Antequera R; Gil E; Rosalmeida MC; Federico MH; Snitcovsky IM
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):270-5. PubMed ID: 21163585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of concurrent granulocyte macrophage-colony stimulating factor on radiation-induced mucositis in head and neck cancer patients: a double-blind placebo-controlled prospective phase III study by Radiation Therapy Oncology Group 9901.
    Ryu JK; Swann S; LeVeque F; Scarantino CW; Johnson D; Chen A; Fortin A; Pollock J; Kim H; Ang KK
    Int J Radiat Oncol Biol Phys; 2007 Mar; 67(3):643-50. PubMed ID: 17293228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of topical misoprostol to reduce radiation-induced mucositis: results of a randomized, double-blind, placebo-controlled trial.
    Veness MJ; Foroudi F; Gebski V; Timms I; Sathiyaseelan Y; Cakir B; Tiver KW
    Australas Radiol; 2006 Oct; 50(5):468-74. PubMed ID: 16981945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte macrophage-colony stimulating factor (GM-CSF) and sucralfate in prevention of radiation-induced mucositis: a prospective randomized study.
    Makkonen TA; Minn H; Jekunen A; Vilja P; Tuominen J; Joensuu H
    Int J Radiat Oncol Biol Phys; 2000 Feb; 46(3):525-34. PubMed ID: 10701730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of sucralfate on mucositis during and following radiotherapy of malignancies in the head and neck region. A double-blind placebo-controlled study.
    Franzén L; Henriksson R; Littbrand B; Zackrisson B
    Acta Oncol; 1995; 34(2):219-23. PubMed ID: 7718260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylaxis of radiation-associated mucositis in conventionally treated patients with head and neck cancer: a double-blind, phase III, randomized, controlled trial evaluating the clinical efficacy of an antimicrobial lozenge using a validated mucositis scoring system.
    El-Sayed S; Nabid A; Shelley W; Hay J; Balogh J; Gelinas M; MacKenzie R; Read N; Berthelet E; Lau H; Epstein J; Delvecchio P; Ganguly PK; Wong F; Burns P; Tu D; Pater J
    J Clin Oncol; 2002 Oct; 20(19):3956-63. PubMed ID: 12351592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinctive mucositis and feeding-tube dependency in cetuximab plus radiotherapy for head and neck cancer.
    Yokota T; Onoe T; Ogawa H; Hamauchi S; Iida Y; Kamijo T; Suda T; Yurikusa T; Nishimura T; Yasui H; Onitsuka T
    Jpn J Clin Oncol; 2015 Feb; 45(2):183-8. PubMed ID: 25420692
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of hydrolytic enzymes in preventing radiation therapy-induced side effects in patients with head and neck cancers.
    Gujral MS; Patnaik PM; Kaul R; Parikh HK; Conradt C; Tamhankar CP; Daftary GV
    Cancer Chemother Pharmacol; 2001 Jul; 47 Suppl():S23-8. PubMed ID: 11561868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of granulocyte macrophage-colony stimulating factor (GM-CSF) on the frequency and severity of radiation mucositis in patients with head and neck carcinoma.
    Kannan V; Bapsy PP; Anantha N; Doval DC; Vaithianathan H; Banumathy G; Reddy KB; Kumaraswamy SV; Shenoy AM
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1005-10. PubMed ID: 9169806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of benzydamine hydrochloride in the prevention of oral mucositis in head and neck cancer patients treated with radiotherapy (>50 Gy) with or without chemotherapy.
    Rastogi M; Khurana R; Revannasiddaiah S; Jaiswal I; Nanda SS; Gupta P; Chufal KS; Bhatt ML
    Support Care Cancer; 2017 May; 25(5):1439-1443. PubMed ID: 27987094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized double-blind, placebo-controlled trial of zinc sulfate supplementation for alleviation of radiation-induced oral mucositis and pharyngitis in head and neck cancer patients.
    Sangthawan D; Phungrassami T; Sinkitjarurnchai W
    J Med Assoc Thai; 2013 Jan; 96(1):69-76. PubMed ID: 23720981
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.